Nova Biomedical Corrects Glucose Meters Over Risk of Misassigned Patient Results
Screen retention errors can misassign patient glucose results in electronic records, leading to one reported injury and a planned software update.
Screen retention errors can misassign patient glucose results in electronic records, leading to one reported injury and a planned software update.
Beckman Coulter Diagnostics received FDA clearance for its new DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer.
Researchers developed a blood test for head and neck cancer associated with HPV that was shown to be more accurate and faster than conventional testing.
The Randox adiponectin assay is a liquid, ready-to-use reagent that can be used on a wide range of clinical chemistry analyzers.
Read MoreThe instrument uses only two reagents, has low reagent consumption, requires only a small sample volume, and incorporates a continuous-loading autoloader that makes the analyzer a walkaway system convenient for all customers.
Read MoreMeasurement of patient sPLA2-llA levels enables clinicians to gain a comprehensive overview of cardiovascular risk factors and can help them tailor treatment accordingly.
Read MoreThe assay’s enzymatic method offers improved specificity and reliability compared to conventional methods.
Read MoreIndustry-leading iQ200 urine microscopy and Aution Max AX-4030 urine chemistry technology offer scalable, harmonized solution to meet customer needs.
Read MoreGlycated albumin provides a sensitive intermediate-term marker for glycemic control in diabetes.
Read MoreQuantitation of vitamin D evaluates patients for vitamin D deficiency, associated with diseases such as osteomalacia, osteoporosis, and rickets.
Read MoreThe only FDA-cleared blood test to aid in predicting coronary heart disease risk in patients with no prior history of cardiovascular events.
Read MoreThe refreshed EasyRA clinical chemistry analyzer offers double the throughput with a rate of up to 240 photometric tests per hour or up to 480 ISEtests per hour.
Read MoreSiemens Healthineers has announced receipt of the CE mark and global commercial availability of its Atellica solution, consisting of flexible, scalable, automation-ready immunoassay and chemistry analyzers.
Read MoreThe company has expanded the capability of its EasyRA clinical chemistry analyzer to provide drugs-of-abuse urine screening.
Read MoreThe Atellica Solution combines clinical chemistry and immunoassay analyzers with sample management components to form a scalable system suited for both mid- and high-volume diagnostic laboratories.
Read MoreBeckman Coulter Diagnostics, along with partner Diazyme Laboratories, has announced FDA premarket notification (510(k)) clearance of a new procalcitonin assay.
Read MoreThis month’s issue features products that will be featured at the American Association for Clinical Chemistry (AACC) meeting in San Diego.
Read MoreThis month’s Product Spotlight features chemistry and integrated analyzers from such companies as MedTest, Sekisui Diagnostics, and Siemens Healthineers.
Read More